Wall Street remains on high alert as Berkshire Hathaway, led by Warren Buffett and CEO Greg Abel, shifts its trading strategy, ending a 14-quarter streak […]
O’Reilly Automotive Q2 2026: Growth, Strategy and Outlook
O’Reilly Automotive (ORLY) reported a strong performance for the second quarter of 2026, highlighted by a 6% increase in comparable store sales and a 10% […]
Delek Logistics Hits Record EBITDA and 54th Distribution Hike
Delek Logistics Partners LP (DKL) delivered a standout performance in Q2 2026, reporting record EBITDA and announcing its 54th consecutive distribution increase, driven by surging […]
BD Beats Q3 Earnings Expectations on Strong Medical Tech Growth
Becton, Dickinson and Company (NYSE:BDX) reported $5 billion in revenue for the third quarter of fiscal 2026, marking a 4.4% increase on an FX-neutral basis […]
Is Deutsche Telekom Still a Bargain After a 78% Surge?
Deutsche Telekom (XTRA:DTE) has delivered a robust 77.9% return over the past five years, yet current valuation metrics suggest the stock remains undervalued relative to […]
Lattice Semiconductor Hits Record Q2: Undervalued or Overhyped?
Lattice Semiconductor (LSCC) reported record-breaking second-quarter results on August 4, pairing the strong performance with a robust Q3 2026 revenue guidance of US$245 million to […]
Occidental Petroleum Eyes $4B Cash Flow Boost by 2030
Occidental Petroleum (OXY) leadership, led by CEO Richard Jackson and CFO Sunil Mathew, confirmed a strategic roadmap during their Q2 2026 earnings call to deliver […]
Cimpress Q4 2026: Canva Partnership and Growth Targets
Cimpress (CMPR) concluded its fiscal year 2026 with a strategic focus on operational excellence, announcing a major partnership with design giant Canva and raising its […]
Is Jackson Financial (JXN) Overvalued After Q2 Earnings?
Jackson Financial (JXN) reported robust Q2 2026 financial results, posting US$168 million in revenue and US$655 million in net income, marking a significant year-over-year increase […]
Johnson & Johnson: What OTTAVA and Talc Deals Mean for JNJ
Johnson & Johnson (JNJ) is betting its future on a pivot toward innovative medicine and MedTech, anchored by the recent FDA authorization of the OTTAVA […]